U.S. stocks are slipping Tuesday following President Donald Trump’s latest escalation against the United States’ trading ...

Acumen Pharmaceuticals, Inc. (ABOS) stock has reached a new 52-week low, trading at $1.31 USD, as investors navigate a turbulent market environment. This latest price point reflects a significant ...

Gilead Sciences reported strong fourth-quarter earnings with significant growth in its HIV and oncology segments.

Wall Street held relatively firm on Tuesday following President Donald Trump’s latest tariff escalation and after the Federal Reserve hinted interest rates may not change for a while. The S&P 500 was ...

Investors and traders as well as CEOs and central bankers continue to adjust to a new administration in Washington, D.C.